Ocular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo by Mott, Kevin R. et al.
Ocular infection of mice with an avirulent recombinant HSV-1
expressing IL-4 and an attenuated HSV-1 strain generates virulent
recombinants in vivo
Kevin R. Mott,1 Steven L. Wechsler,2,3,4 Homayon Ghiasi1
1Center for Neurobiology and Vaccine Development, Ophthalmology Research Laboratories, CSMC Burns & Allen Research
Institute, Los Angeles, CA; 2Virology Research, The Gavin S. Herbert Eye Institute, University of California Irvine, Irvine, CA;
3Department of Microbiology and Molecular Genetics, University of California Irvine, Irvine, CA; 4The Center for Virus Research,
University of California Irvine, Irvine, CA
Purpose: To assess the relative impact of overexpression of interleukin 2 (IL-2), interleukin 4 (IL-4), and interferon
gamma (IFN-γ) expressing recombinant herpes simplex virus type 1 (HSV-1) on altering immune responses in ocularly
infected mice.
Methods: BALB/c mice were co-infected ocularly with avirulent HSV-1 strain KOS and avirulent recombinant HSV-1
expressing murine IL-4 (HSV-IL-4). Controls mice were co-infected with KOS + HSV-IL-2 or KOS + HSV-IFNγ.
Following ocular infection, virus replication in the eye, corneal scarring (CS), and survival were determined. We also
isolated recombinant viruses from eye and trigeminal ganglia of KOS + HSV-IL-4 infected mice.
Results: In this study we found that ocular infection of BALB/c mice with a mixture of HSV-IL-4 and KOS resulted in
increased death and increased eye disease. In contrast, when mice were infected in one eye with KOS and the other eye
with HSV-IL-4 no death or eye disease was seen. Intraperitoneal co-infection of mice with KOS and HSV-IL-4 also did
not result in HSV-1 induced death. Interestingly, ocular infection of mice with a mixture of HSV-IL-2 and KOS did not
have any effect on severity of the disease in infected mice. We isolated recombinant viruses from KOS + HSV-IL-4
infected mice eye and trigeminal ganglia. Some of the isolated viruses were more neurovirulent then either parental virus.
Infection of macrophages with IL-4 expressing virus down-regulated IL-12 production by macrophages.
Conclusions: These results suggest a role for IL-4 in suppression of immune response and generation of virulent viruses
in vivo.
Herpes Simplex virus type 1 (HSV-1) is a neurotropic
virus that spreads from the site of infection (i.e., eye, genital
tract, labial) to the nervous system [1]. In both humans and
animal models of HSV-1, virus establishes a latent infection
in the ganglia [2]. Based on neurovirulence in animal studies,
HSV-1 strains can be classified into two main categories: (1)
Avirulent HSV-1 strains, such as strain KOS, do not kill
BALB/c  mice  or  New  Zealand  White  (NZW)  rabbits
following ocular infection; and (2) virulent HSV-1 strains,
such as McKrae, that kill ~50% or more BALB/c mice and
NZW rabbits following ocular infection [3-6]. Previously it
was shown that footpad infection of mice with a 1:1 mixture
of avirulent HSV-1 strains ANG and KOS resulted in a lethal
infection in 62% of the infected mice [7,8]. The avirulent
phenotype in ANG and KOS appeared to be the result of single
amino acid changes to glycoprotein D (gD) or gB, respectively
[9,10].
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In  contrast,  to  HSV-1  essential  genes  and  the  γ34.5
virulence  gene  [9-11],  deletion  of  the  latency  associated
transcript (LAT) does not alter virulence despite reducing
reactivation in ocularly infected rabbits and mice [12-14].
Using the McKrae derived LAT-deficient virus dLAT2903
[12],  we  previously  constructed  recombinant  viruses
expressing murine IL-2 (HSV-IL-2) and IL-4 (HSV-IL-4),
each driven by the LAT promoter [15,16]. These recombinant
viruses, in contrast to their parental virus, were avirulent in
ocularly  infected  mice  despite  having  similar  replicating
kinetics in tissue culture [15,16]. The HSV-IL-2 recombinant
virus,  but  not  the  HSV-IL-4  recombinant  virus,  induced
central nervous system (CNS) demyelination following ocular
infection of mice [17,18]. In this study we set out to determine
if co-infection with KOS or HSV-IL-4 would block HSV-
IL-2-induced  CNS  demyelination.  Surprisingly,  following
ocular infection of BALB/c mice with a mixture of KOS and
HSV-IL-4, 43% of the infected mice died. We isolated four
viruses from trigeminal ganglia and corneas of mice with
severe neurologic involvement. These viruses showed a wide
range of virulence and corneal scarring. Virulent recombinant
viruses  were  only  generated  using  ocular  co-infection  of
HSV-IL-4 with KOS, and not KOS with HSV-IL-2, HSV-
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2153CD80,  HSV-IFNγ,  HSV-IL-12p35,  or  HSV-IL-12p40
recombinant viruses.
METHODS
Virus, cells, and mice: Plaque-purified HSV-1 strains, KOS,
McKrae, dLAT2903 [12], DM33 [19], HSV-IL-4, and dbl-
IL-4 [20,21] recombinant viruses were grown in rabbit skin
(RS) cell monolayers in minimal essential medium (MEM)
containing 5% fetal calf serum (FCS), as described previously
[22]. McKrae (wild type parental virus for dLAT2903) and
dLAT2903 (LAT[-] parental virus for HSV-IL-4 and DM33)
viruses are virulent at an infectious dose of 2×105 plaque
forming units (PFU)/eye, causing obvious acute eye disease
in  BALB/c  mice  and  NZW  rabbits,  and  killing  ~80%  of
BALB/c mice and ~50% of NZW rabbits. In contrast, KOS,
DM33  (LAT(-)  and  γ34.5  (-)  parental  virus  for  dbl-IL-4,
LAT(-) HSV-IL-4, and LAT(-) and γ34.5 (-)dbl-IL-4 viruses
are severely attenuated. All viruses plaque purified 8 times.
BALB/cJ (female, 6-week-old) mice were obtained from The
Jackson Laboratory (Bar Harbor, ME). Animals were handled
in  accordance  with  the  ARVO  statement  for  the  Use  of
Animals in Ophthalmic and Vision Research.
Ocular infection: Mice were infected ocularly with a mixture
of 1×105 PFU of KOS plus 1×105 PFU of HSV-IL-4, or dbl-
IL-4 per eye in 5 μl of tissue culture media as eye drops
without prior corneal scarification. Some mice were infected
with 2×105 PFU/ eye of KOS in one eye and 2×105 PFU/ eye
of HSV-IL-4 in the other eye. Control mice were infected with
2×105 PFU/ eye of KOS, HSV-IL-4, or dbl-IL-4.
Evaluation of corneal scarring: Clinical eye disease patterns
were determined by examining the eyes of the mice on day 28
post  infection.  HSV-induced  corneal  scarring  (epithelial
keratitis) was evaluated by slit lamp biomicroscopy using 1%
fluorescein  stain.  The  magnitude  of  stromal  disease  was
scored as 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 3.5, or 4, with 0, 1,
2, 3, and 4 representing no disease and disease involving 25,
50, 75, and 100% of the corneal surface, respectively.
Analysis of replication and clearance of HSV-1 from the eye:
Eyes were swabbed once daily on days 1, 3, and 5 post-ocular
infection with a Dacron swab (Spectrum type 1). The swab
was transferred to a 12×75 mm culture tube containing 1 ml
of media, frozen, thawed, and virus titers determined using
standard plaque assays on RS cells.
Infection  of  bone  marrow  (BM)-derived  macrophages  in
vitro:  Monolayers  of  macrophages  isolated  from  BALB/c
mice were infected with 10 PFU/cell of dLAT2903 (HSV-
IL-4 parental virus), HSV-IL-4, or mock-infected. One hour
after infection at 37 °C, virus was removed and the infected
cells were washed three times with fresh media and fresh
media was added to each well. The monolayers including the
media were harvested at 12 and 24 h post infection. RNA
preparation was done as we previously described [23].
TaqMan Real-Time PCR: The expression levels of IL-12p35
and IL-12p40 genes, along with the expression of the cellular
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene
(internal  control)  were  evaluated  using  commercially
available  TaqMan  Gene  Expression  Assays  (Applied
Biosystems,  Foster  City,  CA)  with  optimized  primer  and
probe  concentrations  as  we  previously  described  [23,24].
Primer-probe sets consisted of two unlabeled PCR primers
and the FAM™ dye-labeled TaqMan MGB probe formulated
into a single mixture. The primers and probe used were as
follows: 1) IL-12p35 (ABI ASSAY I.D. Mm00434165_m1 –
Amplicon length=68 bp); 2) IL-12p40 (ABI ASSAY I.D. Mm
01288992_m1 – Amplcon length=109 bp); and 3)IL-4 (ABI
Mm00445259_m1  amplicon  length=79  bp).  GAPDH  was
used  as  an  internal  control  (ABI  ASSAY  I.D.
m999999.15_G1 - Amplicon Length=107 bp). The expression
level of HSV-1 gB was similarly evaluated using custom made
TaqMan Gene Expression Assays (Applied Biosystems). The
gB primers and probe were: forward primer, 5′-AAC GCG
ACG CAC ATC AAG-3′; reverse primer, 5′-CTG GTA CGC
GAT CAG AAA GC-3′; and probe, 5′-FAM-CAG CCG CAG
TAC TAC C-3′. Quantitative real-time PCR was performed
as  we  described  previously  [23].  Real-time  PCR  was
performed in triplicate for each sample from each time point.
Relative  gene  expression  levels  were  normalized  to  the
expression of the GAPDH housekeeping gene (endogenous
loading control).
Southern  analyses:  Briefly,  viral  DNA  was  digested  with
BamHI, the restriction fragments were separated in a 0.9%
agarose gel, transferred to Zeta paper, rinsed in 2× SSC (1×
SSC is 0.15 M NaCl plus 0.015 M sodium citrate) for 5 min,
cross-linked to the membrane by UV light, and DNA-DNA
hybridization  performed  with  32P-labeled  IL-4  DNA  as
previously described [15,25].
Statistical analysis: Fisher’s exact tests were performed using
the computer program Instat (GraphPad, San Diego, CA) to
analyze  survival  and  corneal  scarring  (CS).  Results  were
considered statistically significant when the “p” value was
<0.05.
RESULTS
Co-infection of BALB/c mice with avirulent HSV-IL-4 and
KOS  increases  virulence  in  infected  mice:  Groups  of  70
BALB/c mice from 7 different experiments were infected
ocularly with 2×105 PFU/eye of HSV-IL-4 and KOS at a 1:1
ratio,  while  20  control  mice  per  group  from  4  separate
experiments were infected ocularly with 2×105 PFU/eye of
each virus as described in the Methods. All mice (100%)
infected  with  each  individual  virus  (HSV-IL-4  or  KOS)
survived ocular infection (Table 1). In contrast, only 43%
(30/70) mice infected with a mixture of HSV-IL-4 and KOS
survived.  This  difference  between  mice  infected  with  a
mixture of HSV-IL-4 and KOS compared with mice infected
with each individual virus was highly significant (p=0.0001,
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when mice were infected with KOS in the right eye and HSV-
IL-4 in the left eye no increase in virulence was observed in
infected mice (not shown). In addition, when mice were co-
infected with a mixture of KOS and HSV-IL-2 (instead of
KOS and HSV-IL-4) no increase in virulence was detected
(not shown).
To determine if the increased virulence was associated
with IL-4, additional groups of 30 mice (from 4 separate
experiments)  were  co-infected  with  dbl-IL-4  and  KOS.
Control mice were infected with dbl-IL-4 alone. One hundred
percent  of  the  mice  infected  with  dbl-IL-4  survived  the
infection at both doses (20/20; Table 2), while 7% (2/30) of
mice  infected  with  the  dbl-IL-4  +  KOS  died  (Table  2).
Although this difference did not reach statistical significance,
it should be noted that the dbl-IL-4 parent virus DM33, is
deleted for γ34.5 and LAT, and neither this virus, nor d34.5,
deleted for γ34.5, nor KOS, has ever killed a single mouse or
rabbit in our hands. Thus, the death of 2 mice with the mixture
of dbl-IL-4 + KOS may suggest that this virus mixture was
more virulent than either parent. However, we cannot rule out
that the death of these 2 mice could be due to other reasons as
well. We therefore conclude that mixtures of KOS + a virus
expressing  IL-4  driven  by  the  LAT  promoter  resulted  in
decreased survival (i.e., increased virulence).
Virus replication in mouse tears: The virus titers in the tear
films that had been collected on days 1, 3, and 5 post ocular
infection from mice described in Table 1 were determined
using plaque assays on RS cells. There were no significant
differences among the virus titers in the tear films of mice
infected with HSV-IL-4 + KOS compared with mice infected
with KOS alone or HSV-IL-4 alone (Figure 1). Similarly no
significant  differences  were  detected  in  mice  that  were
infected in their right eye with KOS compared with the same
mice that were infected with HSV-IL-4 on the left eye (Figure
2).  Thus,  it  appears  that  there  was  no  direct  correlation
between acute virus replication in the eye on days 1, 3, or 5
PI and increased virulence in co-infected mice.
Corneal scarring (CS) in surviving mice: CS was measured
in all mice that survived until 28 days after ocular infection
(Table 1). The extent of CS was significantly higher in mice
co-infected with HSV-IL-4+KOS than mice infected with
either HSV-IL-4 or KOS separately (Figure 2; p=0.03 and
p<0.0001,  respectively).  Similarly  CS  was  significantly
higher in mice that were co-infected with dbl-IL-4+KOS than
mice infected with dbl-IL-4 or KOS separately (Figure 3;
p=0.0003). Thus, co-infection of mice with KOS and two
different  recombinant  viruses  expressing  IL-4,  increased
severity of CS in surviving mice.
Virulence  and  CS  with  viruses  isolated  from  eyes  and
trigeminal ganglia of co-infected mice: HSV-1 was isolated
from eyes and TGs of mice co-infected with HSV-IL-4 +
KOS, following euthanasia on day 6 post infection. Tissues
were ground up and total supernatants were grown on RS cells
TABLE 1. MORTALITY OF BALB/C MICE FOLLOWING OCULAR INFECTION WITH MIXTURE OF HSV-1.
Virus Mortality p-value
HSV-IL-4+KOS 30/70 (43%)  
HSV-IL-4 0/20 (0%) 0.0001 (HSV-IL-4+KOS versus HSV-IL-4)
KOS 0/20 (0%) 0.0001 (HSV-IL-4+KOS versus HSV-IL-4)
dbl-IL-4+KOS 2/30 (7%) 0.51 (dbl-IL-4+KOS versus dbl-IL-4)
dbl-IL-4 0/20 (0%)  
       BALB/c mice were infected ocularly with 2x105 PFU/eye of each virus or a mixture of two viruses. Survival was determined
       28 days post infection as described in Materials and Methods. Survival for HSV-IL-4, KOS, dbl-IL-4+KOS, or dbl-IL-4 is from
       four separate experiments, while the data for HSV-IL-4+KOS is from 7 separate experiments. The p-value was calculated using
       Fisher exact.
TABLE 2. MORTALITY OF BALB/C MICE FOLLOWING OCULAR INFECTION WITH VIRUSES ISOLATED FROM EYE OR TG OF CO-INFECTED
MICE.
Virus Mortality
vEye2 0/20 (0%)
vTG2 0/20 (0%)
vEye3 16/20 (80%)
vTG3 4/20 (20%)
       BALB/c mice were infected ocularly with 2×105 PFU/eye of each virus isolated from eye or TG of mice following co-infection
       with HSV-IL-4+KOS mixtures described in Table 1. Survival was determined 28 days post infection as described in the Methods.
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purified and after three cycles of plaque purification, four of
the plaque purified viruses isolated from eyes and TGs were
used  for  further  study.  Groups  of  20  BALB/c  mice  were
infected ocularly with 2×105 PFU/eye of each of the 4 plaque
purified viruses (i.e., vEye2, vTG2, vEye3, or vTG3). All
mice (100%) infected with vEye2 or vTG2 virus survived
ocular infection (Table 2). In contrast, only 80% (16/20) and
20% (4/20) of mice infected with vEye3 and vTG3 survived
ocular infection, respectively. This difference between mice
infected with vEye3 compared with mice infected with each
individual virus was highly significant (p=0.0001, Fisher’s
exact test).
CS was measured in surviving mice shown in Table 2.
The Level of CS for mice infected with vEy2, vTG2, and
vTG3 was the same as mice co-infected with HSV-IL-4+KOS
(Figure 4; p>0.05). However, CS in mice that were infected
with vEye3 virus was significantly higher than other groups
or co-infected mice described in Table 1 (Figure 4; p<0.001).
Thus, as a result of co-infection we have isolated a virus that
is more pathogenic than either individual parental virus or co-
infection with a mixture of both parental viruses.
Structure of isolated viruses: HSV-IL-4 was derived from the
dLAT2903  strain  by  the  insertion  of  the  IL-4  gene  and
restoration of the LAT promoter so that the inserted IL-4 gene
is under control of the endogenous LAT promoter [15]. To
determine if vEye2, vEye3, vTG2, and vTG3 still contain the
IL-4 insert, the genomic structure of each virus was confirmed
by restriction enzyme analysis, and Southern blot (Figure 5).
Similar to HSV-IL-4, the vEye2, vEye3, vTG2, and vTG3
viruses all had the IL-4 insert. The size of the IL-4 insert was
similar to that of IL-4 from pLAT-IL-4 (Figure 5). As expected
KOS DNA was negative for presence of IL-4 (Figure 5). Thus,
the size of the IL-4 gene in the isolated recombinant viruses
was similar to the IL-4 gene in the parental HSV-IL-4 virus.
To confirm that the LAT promoter was functional in the
isolated  viruses,  confluent  monolayers  of  RS  cells  were
infected at a multiplicity of 10 PFU/cell of HSV-IL-4, vEye2,
vEye3, vTG2, or vTG3. Infected cells were collected 24 and
48 h post infection and total RNA was isolated for detection
of the IL-4 transcript by TaqMan RT–PCR as described in the
Methods. At 48 h post infection, the levels of IL-4 transcript
were similar for all viruses, except vTG3, which appeared
higher (Figure 6A; 48 h). This suggested that the increased
neurovirulence of vEye3 was not due to decreased expression
Figure 1. Virus titers in the eyes of mice
following ocular infection. Mice were
ocularly  infected  with  HSV-IL-4  +
KOS, HSV-IL-4, or HSV-1 strain KOS
as  described  in  the  Methods.  The
presence  of  HSV-1  in  tear  films  was
monitored  on  days  1,  3,  and  5  post-
infection,  as  described  in  Methods
section. Each data point represents the
average virus titer from 40 eyes (y-axis).
Data are expressed as average±SEM.
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the level of IL-4 transcript was reduced with vEye3 compared
to parental HSV-IL-4 (Figure 6A; 24 h). Thus, it is possible,
but we think unlikely, that reduced IL-4 expression early in
infection could be involved with increased neurovirulence of
vEye3. HSV gB transcript levels were examined as a control
(Figure 6B). The gB RNA levels followed the same patterns
seen for IL-4 RNA, except for vEye2 which had gB RNA
levels similar to the parental virus at 24 h post infection.
Similar patterns of IL-4 RNA levels were detected when RS
cells were infected for 12 h or 24 h with 1PFU/cell of each
virus (not shown). To confirm that the IL-4 transcripts were
being translated into protein, the media from the infected RS
cells  described  above  were  subjected  to  ELISA  as  we
described  previously  [20].  All  four  viruses  appeared  to
express similar levels of IL-4 (not shown). Together, these
results suggest that the observed increased virulence detected
with the isolated recombinant virus vEYe2 was not due to
reduced expression of IL-4 compared to the parental HSV-
IL-4 virus.
Down-regulation of IL-12p35 and IL-12p40 transcripts in
BM-derived macrophages infected with HSV-IL-4: Since IL-4
is an indicator of TH2 response and macrophages play a major
role in pushing the immune response toward TH1 and away
from TH2 by IL-12 production, we investigated the possibility
of  whether  HSV-IL-4  suppresses  IL-12p35  and  IL-12p40
transcripts. Macrophages were isolated from BALB/c mice
and infected with 10 PFU/cell of HSV-IL-4, dLAT2903, or
mock infected. Infected or mock-infected macrophages were
harvested 12 and 24 h post infection and total RNA was
isolated as described in Materials and Methods. The levels of
IL-12p35 and IL-12p40 mRNAs were quantitated by TaqMan
RT–PCR. Cellular GAPDH mRNA was used as an internal
control. Our results suggest that compared to dLAT2903,
HSV-IL-4 suppressed expression of both IL-12–35 (Figure
7A) and IL-12p40 transcripts (Figure 7B). The pattern of
IL-12p35  and  IL-12p40  transcript  in  KOS  infected
macrophages were similar to that of dLAT2903 (not shown).
These  results  suggest  that  HSV-IL-4  infection  suppresses
IL-12 responses in infected macrophages and this may skew
the TH1 response toward a TH2 response.
DISCUSSION
IL-4  has  a  broad  range  of  biologic  and  immunological
activities [26,27] and is considered an indicator of a TH2
Figure 2. Virus titers in the eyes of mice
following ocular infection. Mice were
ocularly  infected  with  HSV-1  strain
KOS on the right eye and HSV-IL-4 on
the left eye. The presence of HSV-1 in
tear films was monitored on days 1, 3,
and  5  post-infection,  as  described  in
Methods  section.  Each  data  point
represents the average virus titer from
20 eyes (y-axis). Data are expressed as
average±SEM.
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[30], CD8+ TC2 cells [31], mast cells [32], and basophils
[33,34]. In this study, we have shown that ocular infection of
mice with a mixture of two avirulent HSV-1 viruses, in which
one  of  the  viruses  expresses  murine  IL-4  increased  viral
pathogenesis. In contrast, when we co-infected mice with
recombinant  viruses  expressing  other  cytokine  genes  and
HSV-1  strain  KOS  no  increase  of  pathogenesis  and
neurovirulence  was  detected  in  infected  mice.  Our  co-
infection result is similar to mousepox virus expressing IL-4
which has increased virulence [35]. This may be because the
mousepox virus expressing IL-4 resulted in reduced IFN-γ
gene expression [35].
Figure 3. Corneal scarring in co-infected
mice.  Corneal  scarring  in  surviving
mice described in Table 1 was examined
on  day  30  PI  as  described  in  the
Methods.  CS  score  represents  the
average±SEM from 80, 40, 40, 56, and
40 eyes infected with HSV-IL-4+KOS,
HSV-IL-4,  KOS,  dbl-IL-4+KOS,  and
dbl-IL-4, respectively.
Figure  4.  Corneal  scarring  in  mice
infected  with  recombinant  viruses.
Corneal  scarring  in  surviving  mice
described in Table 2 was examined on
day 30 PI as described in the Methods.
CS score represents the average±SEM
from 40, 40, 8, and 32 eyes infected with
vEY2,  vTG2,  vEye3,  or  vTG3,
respectively.
Molecular Vision 2010; 16:2153-2162 <http://www.molvis.org/molvis/v16/a231> © 2010 Molecular Vision
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however the effect of IL-4 expressed by recombinant HSV-1
on  TH1  responses  may  not  be  a  direct  effect.  Our  results
suggest that IL-4 has a suppressive effect on IL-12 expression,
while previously it was shown that exogenous application of
IL-4  is  upregulating  the  production  of  IL-12  [36].  This
discrepancy  could  be  due  to  use  of  a  recombinant  virus
expressing  IL-4  rather  then  adding  rIL-4  to  the  culture.
Interleukin-12  (IL-12)  is  a  pleiotropic  heterodimeric
glycoprotein composed of a 35-kDa α subunit and a 40-kDa
β  subunit  [37,38].  The  IL-12  heterodimer  may  bias  the
response in favor of the production of TH1 cells through its
ability to drive the differentiation of TH0 cells into TH1 cells
[39-41]. Thus, our results may suggest that IL-4 suppression
of IL-12 may bias the TH1 response toward a TH2 response
and this may lead to increase of recombination in vivo. In line
with  this  finding,  previously  we  have  shown  that  HSV-1
replicated to higher titers in the eyes of IL-2−/− mice which
have  higher  TH2  response  then  WT  or  IL-4−/−  mice  [42].
Furthermore, we have reported that in IL-4−/− mice, which are
deficient in IL-4 production, lack a TH2 response, and have
elevated IL-2 response, HSV-1 replicated to lower titers and
ocular HSV-1 replication could be increased by exogenously
added  rIL-4  [42].  Previous  studies  also  have  shown  that
delayed viral clearance was seen in mice challenged with
influenza virus in the presence of exogenously applied IL-4
[43],  following  respiratory  syncytial  virus  infection  of
transgenic mice expressing IL-4 [44], and following infection
of mice with a vaccinia virus recombinant expressing IL-4
[45]. Thus, the present study suggests that IL-4 expressed by
Figure 5. Southern analyses of isolated
viruses.  Subconfluent  RS  cell
monolayers were infected with 10 PFU/
cell of KOS, HSV-IL-4, vEye2, vTG2,
vEye3, and vTG3 viruses for 16 h. Viral
DNAs were isolated, 5 μg of DNA/each
virus  was  digested  with  BamHI,  and
hybridized to 32P-labeled murine IL-4.
pLAT-IL-4  containing  the  full-length
IL-4  was  used  as  positive  control.
Lanes: KOS, HSV-IL-4, vEye2, vTG2,
vEye3, vTG3, and pLAT-IL-4.
Figure 6. Level of IL-4 and HSV-1 gB
transcripts  in  RS  cells  infected  with
different  recombinant  viruses.
Subconfluent  monolayers  of  RS  cells
were infected with 10 PFU/cell of HSV-
IL-4, vEye2, vEye3, vTG2, or vTG3.
Total RNA was isolated 24 and 48hr
post  infection  and  TaqMan  RT–PCR
was  performed  using  IL-4-  and  gB-
specific  primers  as  described  in  the
Methods.  In  each  experiment,  an
estimated relative copy number of IL-4
and gB were calculated using standard
curves  generated  from  pVR1055-IL-4
and pVR1055-gB, respectively. Briefly,
DNA template was serially diluted 10-
fold such that 5 μl contained from 103 to
1011 copies of IL-4 or gB, then subjected
to TaqMan PCR with the same set of
primers. By comparing the normalized
threshold cycle of each sample to the
threshold cycle of the standard, the copy
number  for  each  reaction  was
determined.  GAPDH  was  used  as
internal control. Each point represents
the  mean±SEM  (n=4).  Panel  A
indicated gB and panel B indicates IL-4.
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response from a TH1 to a TH2. Similar to this study, in another
study,  IL-4  expression  by  a  recombinant  vaccinia  virus
exacerbated infection and the IL-4-induced exacerbation was
T cell independent [46].
In  summary,  co-infection  of  two  avirulent  HSV-1  in
which  one  of  the  two  viruses  expressing  IL-4  generated
recombinant viruses in vivo. These recombinant viruses were
more pathogenic and more virulent then their parental viruses.
Infection of macrophages with IL-4 expressing virus down-
regulated IL-12 production by macrophages. These findings
suggest a role for IL-4 in suppression of immune response and
generation of virulent viruses in vivo.
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